Review: Mixed signals from trials concerning pharmacologic prevention of type 2 diabetes mellitus

Kenealy, Tim; Arroll, Bruce
September 2005
ACP Journal Club;Sep/Oct2005, Vol. 143 Issue 2, p44
Academic Journal
The article focuses on a study by researcher R. Padwal and colleagues, which reports on the pharmacologic prevention of type 2 diabetes mellitus. The study found that in patients with type 2 diabetes mellitus, some oral hypoglycemic agents and antiobesity drugs reduce the incidence of diabetes, but the findings are inconsistent and many studies have low patient follow-up or show high drug-related gastrointestinal adverse effects. It is concluded that no single agent is a clear choice for preventing diabetes in patients with impaired glucose tolerance.


Related Articles

  • HYPOGLYCEMIC EFFECT OF BAEL PATRA (AEGLE MARMELOS) IN NIDDM PATIENTS. Sankhla, Aarti; Sharma, Shashi; Sharma, Nidhi // Journal of Dairying Foods & Home Sciences;2009, Vol. 28 Issue 3/4, p233 

    The present study attempted to find the efficacy of bael patra in the management on thirty eight NIDDM patients in the age range of 40-60 years. For the purpose, forty subjects from the two diabetic clinics in Ajmer city were selected and divided in to two groups of twenty subjects each taking...

  • Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents. Bretzel, Reinhard G.; Eckhard, Michael; Landgraf, Wolfgang; Owens, David R.; Linn, Thomas // Diabetes Care;Nov2009 Supplement, Vol. 32, pS260 

    The article discusses a study called A Parallel design comparing an Oral antidiabetic drug combination therapy with either Lantus once daily or Lispro at mealtime in type 2 diabetic patients failing Oral treatment (APOLLO) trial. It notes that the study showed that a once daily basal insulin...

  • VITAL: Paricalcitol reduced renal, CV risks in patients with diabetic nephropathy.  // Endocrine Today;Jan2011, Vol. 9 Issue 1, p24 

    This article discusses the effectiveness of the combination of paricalcitol and renin-angiotension-aldosterone system inhibition in lowering residual renal risk for patients with type 2 diabetes.

  • Strategies for insulin impairment. R.M.D. // Cortlandt Forum;2/25/96, Vol. 9 Issue 2, p124 

    Responds to queries on efficacy of prescribing hypoglycemic agents among non-insulin dependent diabetics. Insulin levels; Recommendations for alternative medication regimen including exercise and proper diet.

  • Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes. Mizushige, Tomoko; Kobori, Hiroyuki; Nishijima, Yoko; Yano, Yuichiro; Sakata, Koji; Hayakawa, Manabu; Nishiyama, Akira // Journal of Diabetes Research;8/25/2015, Vol. 2015, p1 

    Background. The aims of this study were (1) to examine the renoprotective effects of alogliptin and (2) to establish urinary angiotensinogen (AGT) as a prognostic marker of renoprotective effects of alogliptin in patients with type 2 diabetes (T2D). Methods. In 43 patients with T2D (18 women,...

  • Wide Variation in the Sequence of Medications Prescribed for Glycemic Control. Grant, Richard W.; Wexler, Deborah; Lester, William T.; Nathan, David M.; Meigs, James B. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA315 

    Glycemia remains inadequately controlled in the majority of patients with diabetes. Recent guidelines for type 2 diabetes have recommended a parsimonious treatment algorithm beginning with metformin. Our objective was to characterize current clinical practice among patients prescribed a sequence...

  • SECTION 8: ENDOCRINE SYSTEM.  // MPR - Pharmacist's Edition;Summer2010, Vol. 4 Issue 2, p117 

    The article provides information on the use of insulin for the treatment of diabetes. It cites that insulin is used in type 1 diabetes patients and in type 2 diabetes who cannot control their symptoms using diet or exercise. It notes that insulin is given by subcutaneous injection and has...

  • Antidiabetic Drugs and Heart Failure Risk in Patients With Type 2 Diabetes in the U.K. Primary Care Setting. Maru, Shoko; Koch, Gary G.; Stender, Monika; Clark, Douglas; Gibowski, Laura; Petri, Hans; White, Alice D.; Simpson JR., Ross J. // Diabetes Care;Jan2005, Vol. 28 Issue 1, p20 

    OBJECTIVE -- To assess the effects of antidiabetic drugs on the risk of heart failure in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS -- We conducted a retrospective cohort study with a newly diagnosed diabetes cohort of 25,690 patients registered in the U.K. General Practice...

  • Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients - an analysis of the DiaRegis registry.  // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p66 

    The article offers information on the research conducted by the authors related to antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients. It states that the study aimed to identify predictors of anamnestic hypoglycaemia in type-2 diabetic patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics